Antigen-agnostic tumour tagging for CAR T cell therapy

T cells with a chimaeric antigen receptor specific for fluorescein isothiocyanate can be directed against solid tumours via the intratumoural administration of a fluorescein-isothiocyanate-conjugated amphiphile that inserts itself in cell membranes.
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

The cover illustrates that the tagging of tumour cells with an amphiphilic ligand for a chimaeric antigen receptor on T cells allows for the universal redirection of the cells against solid tumours.

See Zhang et al.

Image: Angela Zhang and co-authors. Cover design: Alex Wing.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Biotechnology
Life Sciences > Biological Sciences > Biotechnology

Related Collections

With Collections, you can get published faster and increase your visibility.

Neuroengineering

With this cross-journal Collection, the editors at Nature Biomedical Engineering, Nature Medicine, Nature Neuroscience, Nature Biotechnology, Nature Communications, Communications Medicine, Communications Biology, and Scientific Reports invite manuscripts that highlight the development, use and insight obtained from applying neuroengineering approaches.

Publishing Model: Hybrid

Deadline: Oct 31, 2026

Implantable wireless communication technologies

This collection brings together research that addresses critical engineering challenges in implantable wireless communications. It demonstrates how electromagnetic, optical, acoustic, or hybrid methods can be engineered to achieve reliable wireless communications and power delivery through biological tissues.

Publishing Model: Hybrid

Deadline: Nov 28, 2026